Outlier Medications: They Can Help Our Patients

Volume 41 · Number 3
MARCH 2011

Psychiatr Ann. 2011 March;41(3):137

By Jan Fawcett, MD

This March 2011 issue of Psychiatric Annals, guest edited by Bezalel Dantz, MD, who, along with all but one of the contributors, hails from the department at Rush University Medical Center where I spent 30 years, covers some important and useful medications that we have either lost touch with or take for granted: tricyclics, monoamine oxidase inhibitors (MAOIs), nefazodone, and trazodone.

Underutilized Treatments in Depression and Anxiety

Underutilized Treatments in Depression and Anxiety
Bezalel Dantz, MD

A 21-year-old Woman with Bipolar Disorder
Ghulam-Murtaza Bajwa, MD; Deepa Hasija, MD; Sree Latha Krishna Jadapalle, MD; Amel Badr, MD

CE article Trazodone: The Forgotten Antidepressant
Benjamin Raatjes, MD; Bezalel Dantz, MD

CE article The Tricyclics: More than Just Antidepressants
Aaron Plattner, MD; Bezalel Dantz, MD

CE article Buspirone: Anxiolytic, Antidepressant, or Neither?
John F. Egger, MD; Charles Hebert, MD

CE article The Monoamine Oxidase Inhibitors: Relics Reconsidered
Virginia O'Brien, MD

CE article Nefazodone Revisited
Bezalel Dantz, MD